Cytovene IV and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Cytovene IV and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ganciclovir
Brand name: Cytovene
Synonyms: Cytovene (injection), Cytovene-IV
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cytovene IV-Insulin glargine, recombinant Subcutaneous
- Cytovene IV-Insulin glulisine
- Cytovene IV-Insulin Glulisine (Cartridges and Pens)
- Cytovene IV-Insulin Glulisine (Vials)
- Cytovene IV-Insulin glulisine Subcutaneous
- Cytovene IV-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Cytoxan
- Insulin glargine and lixisenatide Subcutaneous-Cytoxan (Cyclophosphamide Injection)
- Insulin glargine and lixisenatide Subcutaneous-Cytoxan (Cyclophosphamide Tablets)
- Insulin glargine and lixisenatide Subcutaneous-Cytoxan Lyophilized
- Insulin glargine and lixisenatide Subcutaneous-Cytra K Oral Solution
- Insulin glargine and lixisenatide Subcutaneous-Cytra-2